X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
P&G: Restructuring benefits… - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Mar 4, 2003

    P&G: Restructuring benefits…

    P&G Hygiene and Healthcare Limited (PGHH), the two product focused FMCG company (Vicks and Whisper), has had a lacklustre first half in FY03 (the company follows June year ending for accounting). In the period from July - December 2002, the company has reported a marginal 1.3% topline growth, and only 3% bottomline growth.

    (Rs m) 2QFY02 2QFY03 Change 1HFY02 1HFY03 Change
    Net Sales 1,349 1,361 0.9% 2,399 2,430 1.3%
    Other Income 22 5 -78.0% 54 53 -3.1%
    Expenditure 977 909 -6.9% 1,735 1,715 -1.2%
    Operating Profit (EBDIT) 372 452 21.5% 665 716 7.7%
    Operating Profit Margin (%) 27.6% 33.2%   27.7% 29.4%  
    Interest 0 0 - 0 0 -
    Depreciation 58 31 -47.3% 122 62 -48.7%
    Profit before Tax 336 426 26.9% 597 706 18.2%
    Tax 102 92 -9.6% 168 177 5.6%
    Extraordinary items 73 -13 - 73 -13 -
    Profit after Tax/(Loss) 306 320 4.6% 502 516 2.7%
    Net profit margin (%) 22.7% 23.5%   20.9% 21.2%  
    No. of Shares (eoy) (m) 21.6 21.6   21.6 21.6  
    Diluted Earnings per share* 56.6 59.2   46.4 47.7  
    *(annualised)            
    Current P/e ratio   6.5     8.1  

    However, cost controls saw the company expanding its operating margins to 29.4% during 1HFY03. An almost 50% dip in depreciation costs saw probit before tax grow by 18% during the period. Depreciation provisioning has gone down as the company sold its Hyderabad factory assets to a contract manufacturer in January 2003. There will be no profit hit to the company on this transaction. Procter & Gamble Singapore will reimburse the PGHH the separation expenses and loss on sale of the assets.

    Extraordinary items in 1HFY03 (Rs 13 m) is the net of reversal of expenses of prior years (Rs 40 m) and impairment of Honda factory assets no longer in use (Rs 53 m). The dip in depreciation is also on account of this impairment in assets. If we exclude the extraordinary items, then P&G Hygiene's net profit has improved by an encouraging 24% YoY. So PGHH is following the industry trend, wherein its focusing on restructuring its operations to become more profitable, when topline growth is hard to come by.

    Given PGHH’s clear strategy on focusing on two products with premium positioning, the company in the past has continually clocked double-digit growth figures both in topline and bottomline. However, increasing competition is the sanitary napkins market as well as in the anti-cold segment has taken a toll on growth of the company. In FY02, the company finished with a measly 0.4% topline growth, as it has been forced to either reduce its premium on products or offer schemes to boost sales (at one time, a campaign which gave 20% off on 'Whisper' was being run). P&G is also not as strong as the Unilever subsidiary, HLL, in distribution. Of course, both its products have an urban appeal and to that extent distribution strength is not comparable.

    At the current price of Rs 385, the stock trades at 8.1x annualised 1HFY03 earnings and a market cap to sales of 1.7x 1HFY03 earnings. Though the valuation of the company is on the lower side of the FMCG spectrum, the parent's other Indian subsidiaries, the company's niche presence and continuing pricing pressure on its products are the negating factors for investors. Nevertheless, on the positive side, the company is a good dividend payer (it has paid Rs 40 per share as dividend twice in the last four years). Also, the parent may opt to go in for a buyback if the valuations continue to remain sluggish.

     

     

    Equitymaster requests your view! Post a comment on "P&G: Restructuring benefits…". Click here!

      
     

    More Views on News

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    P&G: Strong Core Performance (Quarterly Results Update - Detailed)

    Oct 5, 2016

    Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: A Stable Quarter (Quarterly Results Update - Detailed)

    May 6, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 12% YoY during the quarter.

    P&G: Margins Go Through the Roof (Quarterly Results Update - Detailed)

    Feb 9, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 62% YoY during the quarter.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

    Aug 4, 2017

    The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    P&G HYGIENE SHARE PRICE


    Aug 17, 2017 (Close)

    TRACK P&G HYGIENE

    • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    P&G HYGIENE 5-YR ANALYSIS

    Detailed Financial Information With Charts

    COMPARE P&G HYGIENE WITH

    MARKET STATS